PE8195A1 - ADMINISTRABLE PHARMACEUTICAL FORMULATION IN ORAL FORM CONTAINING RALOXIFENE - Google Patents

ADMINISTRABLE PHARMACEUTICAL FORMULATION IN ORAL FORM CONTAINING RALOXIFENE

Info

Publication number
PE8195A1
PE8195A1 PE1994247411A PE24741194A PE8195A1 PE 8195 A1 PE8195 A1 PE 8195A1 PE 1994247411 A PE1994247411 A PE 1994247411A PE 24741194 A PE24741194 A PE 24741194A PE 8195 A1 PE8195 A1 PE 8195A1
Authority
PE
Peru
Prior art keywords
pharmaceutical formulation
form containing
oral form
administrable pharmaceutical
containing raloxifene
Prior art date
Application number
PE1994247411A
Other languages
Spanish (es)
Inventor
Kerry John Hartauer
Lowell Lee Gibson
Julian Larry Stowers
Stephanie Ann Sweetana
Arvind Lavji Thakkar
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PE8195A1 publication Critical patent/PE8195A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE REFIERE A UNA FORMA FARMACEUTICA, TAL COMO UN COMPRIMIDO O UNA TABLETA, CARACTERIZADA POR COMPRENDER: 1) RALOXIFENO, ASI COMO SUS ESTERES, ETERES Y SALES UTILES EN EL TRATAMIENTO DE TUMORES PROSTATICOS Y MAMARIOS, POR SER ANTIESTROGENOS NO ESTEROIDES Y ANTIANDROGENOS; 2) UN AGENTE TENSIOACTIVO TAL COMO POLISORBATO 80; 3) UN DILUYENTE SOLUBLE EN AGUA TAL COMO LACTOSA; LA CUAL TIENE UNA MAYOR SOLUBILIDAD EN MEDIO ACUOSOIT REFERS TO A PHARMACEUTICAL FORM, SUCH AS A TABLET OR A TABLET, CHARACTERIZED BY UNDERSTANDING: 1) RALOXIFENO, AS WELL AS ITS ESTERS, ETHERS AND SALTS USEFUL IN THE TREATMENT OF NON-CONTROLLED PROSTATIC TUMORS; 2) A SURFACE AGENT SUCH AS POLYSORBATE 80; 3) A THINNER SOLUBLE IN WATER SUCH AS LACTOSE; WHICH HAS A GREATER SOLUBILITY IN AQUEOUS MEDIUM

PE1994247411A 1994-03-02 1994-07-25 ADMINISTRABLE PHARMACEUTICAL FORMULATION IN ORAL FORM CONTAINING RALOXIFENE PE8195A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20491594A 1994-03-02 1994-03-02

Publications (1)

Publication Number Publication Date
PE8195A1 true PE8195A1 (en) 1995-04-14

Family

ID=40909519

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1994247411A PE8195A1 (en) 1994-03-02 1994-07-25 ADMINISTRABLE PHARMACEUTICAL FORMULATION IN ORAL FORM CONTAINING RALOXIFENE

Country Status (6)

Country Link
KR (1) KR100335580B1 (en)
CO (1) CO4340620A1 (en)
MY (1) MY117590A (en)
PE (1) PE8195A1 (en)
TW (1) TW327604B (en)
UA (1) UA39946C2 (en)

Also Published As

Publication number Publication date
CO4340620A1 (en) 1996-07-30
TW327604B (en) 1998-03-01
MY117590A (en) 2004-07-31
KR100335580B1 (en) 2002-11-30
UA39946C2 (en) 2001-07-16

Similar Documents

Publication Publication Date Title
LU90297I2 (en) Rivastigmine its pharmaceutically acceptable salts and derivatives, in particular rivastigmine in the form of hydrogen tartrate
PA8509001A1 (en) DOSAGE FORM OF DRUGS DRIVEN BY A HYDROGEL
UY27682A1 (en) PHARMACEUTICAL COMPOSITIONS
ES2074124T3 (en) COMPOSITION IN THE FORM OF A FOAM CONTAINING 5-AMINOSALICYLIC ACID FOR INTRA-RECTAL ADMINISTRATION.
ES2095964T3 (en) A COMPOSITION OF LIQUID EXCIPIENT THAT FORMS A GEL.
AR025487A2 (en) COMMERCIAL ARTICLE THAT INCLUDES A CONTAINER CONTAINING A WATERPROOF CLEANING SOLUTION THAT CLEANS AND REDUCES A SIGNIFICANT NUMBER OF PRODUCT MICROORGANISMS
ES2160693T3 (en) STABLE FORMULATION OF 10-HYDROXY-7-ETHYL-CAMPTOTECHINE IN THE LACTONE FORM.
ES2075468T3 (en) DRUG SUPPLY VEHICLES SUSPENDED ON A NON-WATER PERFLUORED CARRIER.
DE69531790D1 (en) SHOWER TOWER
ZA200108004B (en) Echinocandin/carbohydrate complexes.
ES2080497T3 (en) BLOCKS FOR CLEANING TOILETS.
RS50089B (en) Ziprasidone suspension
CA2429639A1 (en) Stable azithromycin monohydrate
DK0381617T3 (en) Contact lens disinfectant and cleanser
BG106602A (en) Formulation of substituted benzimidazoles
AR006892A1 (en) USE OF FORMS OF HYALURONIC ACID (HA) FOR THE TREATMENT OF CANCER
AR027504A1 (en) COMPOSITIONS TO DECOLORATE AND HAVE HAIR
MX169821B (en) CREAMY CLEANING COMPOCITIONS
PE8195A1 (en) ADMINISTRABLE PHARMACEUTICAL FORMULATION IN ORAL FORM CONTAINING RALOXIFENE
PE33396A1 (en) COMPOSITION FOR THE TREATMENT OF NICOTINE ANSIA AND / OR ABSTRACT SMOKING SYMPTOMS
MX9203188A (en) BAR COMPOSITION WITH SODIUM CHLORIDE AND STERILE ALCOHOL.
ES2176009T3 (en) USE OF SODIUM CHLORIDE TO REDUCE GASTROINTESTINAL TOXICITY OF COMPETITION DERIVATIVES.
JPS5756420A (en) Bath agent
MY130445A (en) Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone
ES2092559T3 (en) PHARMACEUTICAL FORMULATION CONTAINING PENCICLOVIR.

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed